002589 瑞康医药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资700,70916.65%600,709531,901655,388435,948
投资性房地产660,473-1.72%672,044587,042605,263625,422
固定资产1,976,31315.63%1,709,2241,925,9311,845,5651,975,347
在建工程18,817-93.85%306,180307,339429,340315,367
无形资产488,254-3.64%506,701440,890552,391624,208
商誉146,6680.00%146,668146,668146,668146,685
其他非流动资产935,414-4.08%975,2121,013,831935,5991,389,680
4,926,6470.20%4,916,7374,953,6025,170,2135,512,657

流动资产
货币资金5,746,97353.47%3,744,6264,984,0975,060,7875,340,212
应收账款3,605,784-2.83%3,710,8723,865,2173,762,9884,112,369
存货631,426-11.73%715,297734,7411,119,070954,515
其他流动资产1,038,339-19.03%1,282,3121,500,0921,596,2482,412,460
11,022,52216.60%9,453,10711,084,14711,539,09312,819,556

流动负债
短期借款4,788,97214.01%4,200,5946,096,6856,556,0613,839,835
应付票据3,054,46771.10%1,785,229603,383448,5995,157,359
应付帐款1,795,747-9.07%1,974,9122,779,3313,274,0302,557,392
其他流动负债595,219-15.11%701,190465,222482,428913,850
10,234,40518.15%8,661,9269,944,62110,761,11812,468,437
流动资产净值788,116-0.39%791,1821,139,526777,975351,119
资产总额减流动负债5,714,7630.12%5,707,9196,093,1285,948,1885,863,777

非流动负债
长期借款215,279-8.28%234,714327,081261,27467,200
应付债券0--0000
其他非流动负债48,628-3.64%50,46357,35749,93745,244
263,907-7.46%285,177384,438311,211112,444

总权益
    实收股本1,504,7100.00%1,504,7101,504,7101,504,7101,504,710
    储备项目3,803,8920.24%3,794,9234,043,7773,943,0833,902,622
股东权益5,308,6030.17%5,299,6345,548,4885,447,7945,407,332
非控股权益142,25315.55%123,108160,202189,183344,000